Sugi Predict

Sugi Predict / Compounds / SCHEMBL4039353

SCHEMBL4039353

SCHEMBL4039353

COc1cc(Nc2nc(N)n(-c3ccccn3)n2)ccc1OCCCCN1CCOCC1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 15/20 0.71
▸ KIT P10721 10/20 0.68
▸ IRAK4 Q9NWZ3 4/20 0.68
▸ JAK2 O60674 2/20 0.68
▸ AURKA O14965 1/20 0.68
▸ AXL P30530 5/20 0.62
▸ ABL1 P00519 1/20 0.51
▸ LCK P06239 1/20 0.51
▸ LYN P07948 1/20 0.51
▸ MET P08581 1/20 0.51
▸ PDGFRB P09619 1/20 0.51
▸ SRC P12931 1/20 0.51
▸ FGFR3 P22607 1/20 0.51
▸ KDR P35968 1/20 0.51
▸ JAK3 P52333 1/20 0.51
▸ TEK Q02763 1/20 0.51
▸ KARS1 Q15046 1/20 0.51
▸ ATM Q13315 1/20 0.49
▸ BACE1 P56817 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4041990 0.98 FLT3 (0.74) FLT3KITIRAK4JAK2AURKA
SCHEMBL4041228 0.95 FLT3 (0.70) FLT3KITIRAK4JAK2AURKA
SCHEMBL4037593 0.91 FLT3 (0.69) FLT3KITIRAK4JAK2AURKA
SCHEMBL4042846 0.89 FLT3 (0.72) FLT3KITIRAK4JAK2AURKA
SCHEMBL12779847 0.89 AXL (0.71) FLT3KITIRAK4JAK2AURKA
SCHEMBL4042140 0.89 FLT3 (0.73) FLT3KITIRAK4JAK2AURKA
SCHEMBL14369652 0.86 AXL (0.69) FLT3KITIRAK4JAK2AURKA
SCHEMBL12780015 0.86 FLT3 (0.54) FLT3KITIRAK4JAK2AURKA
SCHEMBL4036507 0.85 FLT3 (0.83) FLT3KITIRAK4JAK2AURKA
SCHEMBL4039626 0.85 FLT3 (0.67) FLT3KITIRAK4JAK2AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902239-B2 Diaminotriazoles useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-03-08 — — US disclosed
US-7902239-B2 Diaminotriazoles useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-03-08 — — US disclosed
EP-1562589-B1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2009-01-07 — — EP disclosed
EP-1562589-B1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2009-01-07 — — EP disclosed
US-20080014189-A1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED 2008-01-17 — — US disclosed
US-20080014189-A1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED 2008-01-17 — — US disclosed
US-7279469-B2 Diaminotriazoles useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-10-09 — — US disclosed
US-7279469-B2 Diaminotriazoles useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080014189-A1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES MAP3K20, MAP3K1, MAP3K5 FLT3 220/4885KIT 1144/4885IRAK4 566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.